Literature DB >> 15103226

Ghrelin inhibits prolactin secretion in prepubertal rats.

Manuel Tena-Sempere1, Enrique Aguilar, Rafael Fernandez-Fernandez, Leonor Pinilla.   

Abstract

Ghrelin, a novel 28-amino-acid peptide primarily expressed in stomach and hypothalamus, has recently emerged as the endogenous ligand for the GH-secretagogue receptor with ability to stimulate GH secretion in humans and rats. In addition, ghrelin also stimulates prolactin (PRL) secretion in humans. However, its role in the regulation of PRL secretion in rats remains largely unknown. In this context, the present experiments were carried out to analyze the effects of ghrelin on PRL secretion in male and female rats. In detail, the ontogeny and potential sexual dimorphism in the PRL response to ghrelin was evaluated. In addition, the hypothalamic and/or pituitary site of primary action of ghrelin, as well as the possible interactions between ghrelin and other neurotransmitters, as nitric oxide, dopamine, serotonin or excitatory amino acids, in the precise control of PRL secretion were assessed. Experiments were conducted in prepubertal male and female animals. Systemic (i.p.) and central (i.c.v.) administration of ghrelin significantly inhibited PRL secretion. Such an inhibitory effect became evident after day 10 of age, was similar in males and females, and was also observed in hyperprolactinemic aged female rats. In contrast, however, challenge of pituitary samples in vitro with increasing doses of ghrelin (10(-9)-10(-7)M) failed to inhibit PRL secretion. Analysis of interactions between ghrelin and other systems involved in the control of PRL secretion revealed that neither blockade of dopaminergic receptors with domperidone, nor enhancement of serotoninergic tone with fluoxetine + 5-hydroxytryptophan altered the inhibitory response to ghrelin in terms of PRL secretion. Similarly, blockade of nitric oxide synthases with L-nitro-arginine-methyl ester failed to modify the magnitude of ghrelin-induced inhibition of PRL secretion, whereas ghrelin was unable to further decrease serum PRL levels after activation of ionotropic excitatory amino acid receptors by administration of NMDA or AMPA. In conclusion, our data indicate that ghrelin is able to inhibit PRL secretion in male and female rats, likely through an extrapituitary primary site of action that is independent of nitric oxide, dopamine, and serotonin systems. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103226     DOI: 10.1159/000077271

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54.

Authors:  V M Navarro; R Fernández-Fernández; J M Castellano; J Roa; A Mayen; M L Barreiro; F Gaytan; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

2.  Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axis.

Authors:  V M Navarro; R Fernández-Fernández; R Nogueiras; E Vigo; S Tovar; N Chartrel; O Le Marec; J Leprince; E Aguilar; L Pinilla; C Dieguez; H Vaudry; M Tena-Sempere
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

3.  The effects of 5-hydroxytryptophan in combination with different Fatty acids on gastrointestinal functions: a pilot experiment.

Authors:  Helene Sauer; Isabelle Mack; Silke Kohler; Stefanie Siegle; Nicole Rieber; Stephan Zipfel; Bärbel Otto; Yvonne Ritze; Stephan C Bischoff; Paul Enck
Journal:  Gastroenterol Res Pract       Date:  2014-08-19       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.